DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,294 filers reported holding DANAHER CORPORATION in Q4 2018. The put-call ratio across all filers is 1.15 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $2,967,000 | -14.6% | 10,115 | -4.2% | 0.42% | -3.0% |
Q4 2021 | $3,473,000 | -36.3% | 10,557 | -41.0% | 0.43% | +1.2% |
Q3 2021 | $5,452,000 | +13.7% | 17,907 | +0.2% | 0.43% | +13.3% |
Q2 2021 | $4,796,000 | -0.1% | 17,872 | -16.2% | 0.38% | +10.6% |
Q1 2021 | $4,802,000 | -7.1% | 21,333 | -8.3% | 0.34% | -4.5% |
Q4 2020 | $5,167,000 | +11.6% | 23,259 | +8.2% | 0.36% | -10.8% |
Q3 2020 | $4,630,000 | +65.9% | 21,502 | +36.3% | 0.40% | +11.1% |
Q2 2020 | $2,790,000 | +30.9% | 15,780 | +2.5% | 0.36% | -8.4% |
Q1 2020 | $2,132,000 | +29.4% | 15,401 | +43.5% | 0.39% | +33.3% |
Q4 2019 | $1,647,000 | +3.7% | 10,732 | -2.4% | 0.29% | -1.7% |
Q3 2019 | $1,589,000 | +0.1% | 11,001 | -1.0% | 0.30% | +0.3% |
Q2 2019 | $1,588,000 | +11.1% | 11,112 | +2.7% | 0.30% | +6.0% |
Q1 2019 | $1,429,000 | +30.6% | 10,824 | +2.0% | 0.28% | +12.4% |
Q4 2018 | $1,094,000 | -11.2% | 10,611 | -6.4% | 0.25% | -11.3% |
Q3 2018 | $1,232,000 | -4.6% | 11,336 | -13.4% | 0.28% | +4.4% |
Q2 2018 | $1,292,000 | -10.5% | 13,090 | -11.2% | 0.27% | +1.1% |
Q1 2018 | $1,443,000 | -6.0% | 14,741 | -2.3% | 0.27% | +2.7% |
Q4 2017 | $1,535,000 | +6.4% | 15,086 | -1.3% | 0.26% | -1.9% |
Q3 2017 | $1,443,000 | +2.0% | 15,283 | +1.9% | 0.26% | +0.8% |
Q2 2017 | $1,415,000 | +83.8% | 15,005 | +122.2% | 0.26% | +20.1% |
Q1 2017 | $770,000 | -83.6% | 6,754 | -88.2% | 0.22% | +11.2% |
Q4 2016 | $4,683,000 | +4.6% | 57,171 | +0.1% | 0.20% | -12.8% |
Q3 2016 | $4,479,000 | -46.0% | 57,141 | -28.3% | 0.23% | -24.2% |
Q2 2016 | $8,287,000 | +8.9% | 79,677 | +2.0% | 0.30% | +4.2% |
Q1 2016 | $7,608,000 | -43.7% | 78,141 | -46.3% | 0.29% | +10.4% |
Q4 2015 | $13,504,000 | +21.6% | 145,388 | +13.7% | 0.26% | +9.7% |
Q3 2015 | $11,107,000 | -14.3% | 127,866 | -15.6% | 0.24% | -4.5% |
Q2 2015 | $12,963,000 | +1.9% | 151,452 | +1.1% | 0.25% | +3.3% |
Q1 2015 | $12,724,000 | -1.1% | 149,873 | -0.2% | 0.24% | -1.6% |
Q4 2014 | $12,866,000 | +12.2% | 150,107 | -0.5% | 0.24% | +6.1% |
Q3 2014 | $11,463,000 | -5.6% | 150,814 | -2.8% | 0.23% | -1.7% |
Q2 2014 | $12,145,000 | +5.1% | 155,226 | +0.5% | 0.23% | +1.3% |
Q1 2014 | $11,557,000 | -37.4% | 154,390 | -35.4% | 0.23% | -5.0% |
Q4 2013 | $18,462,000 | +7.7% | 239,138 | -3.3% | 0.24% | +3.0% |
Q3 2013 | $17,143,000 | -4.5% | 247,319 | -12.8% | 0.24% | +6.3% |
Q2 2013 | $17,951,000 | – | 283,593 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |